Similar articles

• Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis.

  Norman JT, Gatti L, Wilson PD, Lewis M. Norman JT, et al. Exp Nephrol. 1995 Mar-Apr;3(2):88-9. Exp Nephrol. 1995. PMID: 7773643 No abstract available.
• A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.

  Moore WG, Birkedal-Hansen B, Pierson M, Birkedal-Hansen H. Moore WG, et al. Matrix Suppl. 1992;1:319-20. Matrix Suppl. 1992. PMID: 1480050 No abstract available.
• Collagen turnover in renal disease.

  Costigan M, Chambers DA, Boot-Handford RP. Costigan M, et al. Exp Nephrol. 1995 Mar-Apr;3(2):114-21. Exp Nephrol. 1995. PMID: 7773630 Review. No abstract available.
• Matrix metalloproteinases and their inhibitors.

  Murphy G. Murphy G. Acta Orthop Scand Suppl. 1995 Oct;266:55-60. Acta Orthop Scand Suppl. 1995. PMID: 8553862 Review. No abstract available.
• Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).

  Dittmann KH, Lottspeich F, Ries C, Petrides PE. Dittmann KH, et al. Exp Hematol. 1995 Feb;23(2):155-60. Exp Hematol. 1995. PMID: 7828672